Sometimes the devil is in the details, but device makers had a broad set of concerns about the July draft guidance for the use of real-world evidence (RWE) in regulatory decision-making. Among the comments are those reflecting concern about the potential need for investigational device exemptions for some uses of RWE, and a perception that the scope of the draft seemed to exclude class II devices.